Fractyl Health (GUTS) Asset Utilization Ratio (2024)

Fractyl Health's (GUTS) quarterly Asset Utilization Ratio came in at 0.0 in Q4 2024, up 11.53% on a QoQ basis from 0.0 in Q3 2024.

Fractyl Health (GUTS) Asset Utilization Ratio (2024) Analysis & Trends

Fractyl Health (GUTS) has 1 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q4 2024.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.0 (changed N/A YoY) and the FY2024 annual result came in at 0.0, changed N/A from the prior year.
Asset Utilization Ratio climbed to 0.0 in Q4 2024, from 0.0 in the prior quarter.
In the past five years, Asset Utilization Ratio ranged from a high of 0.0 in Q1 2024 to a low of 0.0 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	139.94 Bn	132.09 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	86.59 Bn	78.60 Bn	3.93 Bn	0.38
3	Argenx Se	65.67 Bn	60.49 Bn	1.37 Bn	-
4	Moderna	57.81 Bn	52.67 Bn	52.00 Mn	0.20
5	BeOne Medicines	42.25 Bn	37.15 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.76 Bn	28.45 Bn	992.69 Mn	0.90
7	BioNTech SE	28.41 Bn	10.02 Bn	668.28 Mn	0.13
8	Insmed	27.58 Bn	26.42 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.24 Bn	26.41 Bn	-	0.13
10	Fractyl Health	125.70 Mn	125.70 Mn	-	-

Download Data